COX and cancer.
Mazhar
D
D
Department of Cancer Medicine, Imperial College of Science, Technology & Medicine, London.
Gillmore
R
R
Waxman
J
J
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D004357:Drug Synergism; D006801:Humans; D008134:Long-Term Care; D008297:Male; D009361:Neoplasm Invasiveness; D009369:Neoplasms / Q000201:enzymology / Q000517:prevention & control*; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic
D052246:Cyclooxygenase 2 Inhibitors